Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties

Drug Development and Industrial Pharmacy

Volumn 25, Issue 2, 1999, Pages 197-203

  Otsuka, Makoto ^a   Ofusa, Tomoko ^a   Matsuda, Yoshihisa ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYBUZOLE;

ARTICLE; CRYSTALLIZATION; DRUG SOLUBILITY; DRUG STABILITY; SOLVATION; X RAY DIFFRACTION;

CHEMISTRY, PHYSICAL; CRYSTALLIZATION; DIFFERENTIAL THERMAL ANALYSIS; DOSAGE FORMS; DRUG STABILITY; DRUG STORAGE; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SULFONAMIDES; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 0032967393     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102160     Document Type: Article

References (10)

1. FDA Guide to Inspections of Oral Solid Dosage Forms Pre/Post Approval Issues for Development and Validation, 1994.
2. S. A. Khalil, M. A. Moustafa, A. R. Ebian, and M. M. Motawai, J. Pharm. Sci., 61, 1615 (1972).
3. J. K. Haleblian, J. Pharm. Sci., 64, 1269 (1975).
4. H. W. Gouda, M. A. Moustafa, and H. I. Al-Shora, Int. J. Pharm., 18, 213 (1984).
5. H. E. Kissinnger, J. Res. Natl. Bur. Std., 57, 217-221 (1956).
6. M. Otsuka, M. Onoe, and Y. Matsuda, Pharm. Res., 10, 577-582 (1993).
7. M. Otsuka, R. Teraoka, and Y. Matsuda, Pharm. Res., 8, 1066-1068 (1991).
8. K. Sekiguchi, K. Shirotani, O. Sakata, and E. Suzuki, Chem. Pharm. Bull., 32, 1558-1567 (1984).
9. J. M. Criado, J. Morales, and V. Rives, J. Therm. Anal., 14, 221-228 (1978).
10. M. Otsuka and Y. Matsuda, Chem. Pharm. Bull., 42, 2382-2384 (1994).